First Personal Financial Services Trevena Inc Transaction History

First Personal Financial Services

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 07, 2018	SELL	$1.44 - $2.24 $331 - $515	-230 Closed	0 $0
Q1 2018 May 10, 2018	SELL	$1.51 - $2.06 $226 - $309	-150 Reduced 39.47%	230 $0
Q3 2017 Nov 01, 2017	BUY	$2.22 - $2.79 $843 - $1,060	380	380 $1,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $724M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of First Personal Financial Services, based on Form 13F filings with the SEC.

Stay updated on First Personal Financial Services with notifications on news.